Advertisement

Abstract

The introduction of radioimmunoassay (RIA) methods in the early 1960s permitted accurate measurement of individual pituitary hormones (Laron 1969) and the diagnosis of various types of pituitary insufficiency (Laron 1981a). It soon became possible not only to deflne a disease entity such as isolated human pituitary growth hormone (hGH) deficiency but also to diagnose partial defects and transitory deficiencies.

Keywords

Growth Hormone Human Growth Hormone Isolate Growth Honnone Deficiency Pituitary Dwarfism Human Pituitary Growth Hormone 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Abramovici A, Josefsberg Z, Mimouni M, Liban E, Laron Z (1983) Histopathological features of the skin in hypopituitarism in Laron type dwarfism. Israel J Med SeiGoogle Scholar
  2. Adam A, Josefsberg Z, Pertzelan A, Zadik Z, Chemke JM, Laron Z (1981) Occurrence of four types of growth hormone related dwarfism in Israeli communities. Eur J Pediatr 137: 35–39PubMedCrossRefGoogle Scholar
  3. Alcaniz JJ, Salto L, Barcelo B (1978) GH secretion in two siblings wiht Laron’s dwarfism: the effects of glucose, arginine, somatostatin and bromoeryptine. J Clin Endocrinol Metab 47: 453–456PubMedCrossRefGoogle Scholar
  4. Anderson WF, Fletcher JD (1980) Gene therapy in human beings: when is it ethical to begin? N Engl J Med 303: 1293–1296PubMedCrossRefGoogle Scholar
  5. Arad I, Laron Z (1979) Standards for upper/lower body segment ratio/sitting height — sub-ischial leg length from birth to 18 years in girls and boys. In: Proceedings of Ist International Congress of Auxology, Rome. Centro Auxologica Italiano di Piancavallo, Milan, pp 159-164Google Scholar
  6. Carr B, Friesen HG (1976) Growth hormone and insulin binding to human liver J Endocrinol Metab 42: 484–493Google Scholar
  7. Clemons RD, Costing G, Kogut MD (1976) Laron dwarfism: growth and immunore-active insulin following treatment with human growth hormone. J Pediatr 88: 427–433PubMedCrossRefGoogle Scholar
  8. Collado F, Martull MV, Torreblanca J, Fernandez A (1971) Enanismo familiar con niveles altos de hormona de crescimento ( GH) y falta de respuesta periferica a la hormona de crescimento humana exogena (hGH) y a la testosterona. Bol S Ped Madr 18: 7–16Google Scholar
  9. Daughaday WH (1981) Growth hormone and the somatomedins. In: Daughaday WH (ed) Endocrine control of growth. Elsevier, North Holland, New York Oxford, pp 1–24Google Scholar
  10. Daughaday WH, Laron Z, Pertzelan A, Heins JN (1969) Defective sulfation factor generation: a possible etiological link in dwarfism. Trans Assoc Am Physicians 82: 129–138PubMedGoogle Scholar
  11. Eiders MJ, Garland JT, Daughaday A, Fisher DA, Whitney JE, Hughes ER (1973) Laron’s dwarfism: studies on the nature of the defect. J Pediatr 83: 253–263CrossRefGoogle Scholar
  12. Eshet R, Laron Z, Brown M, Arnon R (1973) Immunoreactive properties of the plasma hGH from patients with the Syndrome of familial dwarfism and high plasma IR-hGH. J Clin Endocrinol Metab 37: 819–821PubMedCrossRefGoogle Scholar
  13. Eshet R, Laron Z, Brown M, Arnon R (1974) Immunological behaviour of hGH from plasma of patients with familial dwarfism and high IR-hGH in a radioimmunoassay system using the cross reaction between hGH and HCS. Horm Metab Res 6: 80–81PubMedCrossRefGoogle Scholar
  14. Eshet R, Peleg S, Josefsberg Z, Laron Z (1981) Characterization of hGH from patients with LTD by a human liver radioreceptor assay (RRA) ( Abstr ). Pediatr Res 15: 89Google Scholar
  15. Eshet R, Laron Z, Pertzelan A, Arnon R, Dintzman M (in press) Defect of hGH receptors in the liver of 2 patients with Laron type dwarfism. Isr J Med SeiGoogle Scholar
  16. Frankel JJ, Laron Z (1968) Psychological aspects of pituitary insufficiency in children and adolescents with special reference to growth hormone. Isr J Med Sei 4:953–961Google Scholar
  17. Frasier SD, Smith FG Jr (1966) Antibodies to human growth hormone. Development during therapy with human growth hormone. Am J Dis Child 112: 383–388Google Scholar
  18. Galatzer A, Rosenblith E, Laron Z (1978) Psychological and rehabilitation aspects of short stature and delayed puberty. In: Gedda L, Parisi P (eds) Auxology: Human growth in health and disorder. Academic Press, London, pp 303 — 311Google Scholar
  19. Golde DW, Bersch N, Kaplan SA, Rimoin DL, Li CH (1980) Peripheral unresponsiveness to human growth hormone in Laron dwarfism. N Engl J Med 303: 1156–1159PubMedCrossRefGoogle Scholar
  20. Goodman AD,Tanenbaum R, Rabinowitz D (1972) Existence of two forms of immunoreactive growth hormone in human plasma. J Clin Endocrinol Metab 35: 868–878CrossRefGoogle Scholar
  21. Jacobs LS, Sneid DS, Garland JT, Laron Z, Daughaday WH (1976) Receptor active growth hormone in Laron dwarfism. J Clin Endocrinol Metab 42: 403–406PubMedCrossRefGoogle Scholar
  22. Rastrup KW, Andersen H, Hanssen KF (1975) Increased immunoreactive plasma and urinary growth hormone in growth retardation with defective generation of somatomedin A ( Laron’s Syndrome ). Acta Paediatr Scand 64: 613–618Google Scholar
  23. Kleine TO, Merten B, Meier HW, Nevo Z, Kowadlo Silbergeld A, Mamet R, Laron Z (1980) Effect of normal and pathological sera of patients with low serum somatomedin levels on prteoglycan glycosaminoglyean biosynthesis in two types of cartilage. In: Robert AM, Robert L (eds) Biochimie des tissue conjonctifs normaux et pathologiques. CNRS Editions, Paris, pp 173–175Google Scholar
  24. Konfino R, Pertzelan A, Laron Z (1975) Cephalometric measurements of familial dwarfism and high plasma immunoreactive growth hormone. Am J Orthod 68: 196–201PubMedCrossRefGoogle Scholar
  25. Laron Z (1969) The hypothalamus and the pituitary gland (hypophysis). In: Hubble DW (ed) Paediatric endocrinology, Blackwell, Oxford, pp 35–111Google Scholar
  26. Laron Z (1974) Syndrome of familial dwarfism and high plasma immunoreactive growth hormone. Isr J Med Sei 10: 1247–1253Google Scholar
  27. Laron Z (1977) Syndrome of familial dwarfism and high plasma immunoreactive growth hormone (IR-hGH) — Laron type dwarfism. Paediatrician 6: 106–117Google Scholar
  28. Laron Z (1981a) Clinical aspects of pituitary dwarfism and related conditions. In: Daughaday WH (ed) Endocrine control of growth. Elsevier, North Holland, New York, pp 175–205Google Scholar
  29. Laron Z (1981b) Nutrition and growth factors with special emphasis on proteins. In: Beers RF, Bassett EG (eds) Nutritional factors: Modulating effects on metabolic Processes, Raven Press, New York, pp 337–354Google Scholar
  30. Laron Z (1982) Somatomedin, insulin, growth hormone and growth. Isr J Med Sei 18: 823–829Google Scholar
  31. Laron Z, Galatzer A (1980) Aspects of brain development in children and adolescents with pituitary growth hormone deficiency. In: De Wied D, Van Keep PA (eds) Hormones and the brain. MTP Press, Lancaster, pp 293–302CrossRefGoogle Scholar
  32. Laron Z, Karp M (1980) Carbohydrate metabolism in the Syndrome of familial and high plasma immunoreactive growth hormone (Laron type dwarfism). In: Podolsky S, Viswanathan M (eds) Secondary diabetes: The spectrum of the diabetic Syndrome. Raven Press, New York, pp 363–371Google Scholar
  33. Laron Z, Pertzelan A, Mannheimer S (1966) Genetic pituitary dwarfism with high serum concentration of growth hormone. A new inborn error of metabolism? Isr J Med Sei 2: 152–155Google Scholar
  34. Laron Z, Karp M, Dudek M, Kowadlo Silbergeld A, Harel D (1968a) A contribution to the fat mobilizing activity of human growth hormone. Helv Paediatr Acta 23: 37–44PubMedGoogle Scholar
  35. Laron Z, Pertzelan A, Karp M (1968b) Pituitary dwarfism with high serum levels of growth hormone. Isr J Med Sei 4: 883–894Google Scholar
  36. Laron Z, Pertzelan A, Karp M, Kowadlo Silbergeld A, Daughaday WH (1971) Administration of growth hormone to patients with familial dwarfism with high plasma immunoreactive growth hormone. Measurement of sulfation factor, metabolic and linear growth responses. J Clin Endocrinol Metab 33: 332–342Google Scholar
  37. Laron Z, Karp M, Pertzelan A, Kauli R, Keret R, Doron M (1972) The Syndrome of familial dwarfism and high plasma immunoreactive human growth hormone (IR-hGH). In: Pecile A, Muller EE (eds) Growth and growth hormone. Exceprta Medica, Amsterdam, pp 458–482Google Scholar
  38. Laron Z, Doron M, Josefsberg Z, Klonizky S, Weissman I (1974) Plasma glucagon response to arginine infusion in children with isolated hGH deficiency, panhypopituitarism and familial dwarfism and high plasma IR-hGH deficiency. In: Luft R, Yalow RS (eds) Radioimmunoassay: methodology and applications in physiology and in clinical studies. Horm Metab Res [Suppl] 5: 162–166Google Scholar
  39. Laron Z, Pertzelan A, Karp M (1975) Glucose intolerance in children and young adults with dwarfism due to hGH deficiency and with the Syndrome of dwarfism and high plasma IR-hGH. In: Laron Z, Karp M (eds) Diabetes in juveniles, Modern Problems in pediatrics, vol 12. Karger, Basel London New York, pp 109–117Google Scholar
  40. Laron Z, Pertzelan A, Doron M, Assa S, Keret R (1977) The effect of dihydrosomatostatin in dwarfism with high plasma immunoreactive growth hormone. Horm Metab Res 9: 338–339PubMedCrossRefGoogle Scholar
  41. Laron Z, Arad J, Gurewitch R, Grunebaum M, Dickerman Z (1980a) Age at first conscious ejaculation: a milestone in male puberty. Helv Paediatr Acta 35: 13–30PubMedGoogle Scholar
  42. Laron Z, Kowadlo Silbergeld A, Eshet R, Pertzelan A (1980b) Growth hormone resistance. Ann Clin Res 12: 269–277PubMedGoogle Scholar
  43. Laron Z, Sarel R, Pertzelan A (1980c) Puberty in Laron type dwarfism. Eur J Pediatr 134: 79–83PubMedCrossRefGoogle Scholar
  44. Martin JB (1983) Neuroendocrine regulation of growth hormone secretion. In: Laron Z, Butenandt O (eds) Evaluation of growth hormone secretion, pediatric and adolescent endoerinology, vol 12. Karger, BaselGoogle Scholar
  45. McCoy EE, Bala RM (1978) Somatomedin deficiency (Laron type) dwarfism in Eskimo children ( Abstr. ). Clin Res 26: 845AGoogle Scholar
  46. Merimee TJ, Hall J, Rabinowitz D, McKusick VA, Rimoin DL (1968) An unusual variety of endoerine dwarfism: subresponsiveness to growth hormone in a sexually mature dwarf. Lancet II: 191-193Google Scholar
  47. Merimee TJ, Finberg SE, McKusick VA, Hall J (1970) Diabetes mellitus and sexual ateleiotic dwarfism: a comparative study. J Clin Invest 49: 1096–1102PubMedCrossRefGoogle Scholar
  48. Moses AC, Nissley SP, Passamani J, White RM (1979) Further characterization of growth hormone-dependent somatomedin-binding proteins in rat serum and demonstration of somatomedin binding proteins produced by rat liver cells in culture. Endoerinology 104: 536–546CrossRefGoogle Scholar
  49. Najjar SS, Khachadurian AK, Ilbawl MN, Blizzard RM (1971) Dwarfism with elevated levels of plasma growth hormone. N Engl J Med 284: 809–812PubMedCrossRefGoogle Scholar
  50. Nevo Z, Mimouni M, Laron Z (1977) Growth Parameters of cultured skin fibroblasts and growth promoting activity of sera from patients with growth disturbances ( Abstr. ). Isr J Med Sei 33: 1242Google Scholar
  51. Pertzelan A, Adam A, Laron Z (1968) Genetic aspects of pituitary dwarfism due to absence or biological inactivity of growth hormone. Isr J Med Sei 4: 895–900Google Scholar
  52. Pierson M, Malaprade D, Fortier G, Belleville F, Lasbennes A, Wuilbercq L (1978) Le nanisme familial de type Laron, deficit gentique primaire en somatomedine. Arch Fr Pediatr 35: 151–164PubMedGoogle Scholar
  53. Pombo JLH, Lozano I, Ruiz-Valdepenas MP, Arrieta F, Rodrigues-Minon JL (1973) Enanismo familiar com niveles elevados de STH immunoreactive. Rev Clin Esp 131: 149–152Google Scholar
  54. Posner BI, Kelly PA, Shin RPC, Frisen HG (1974) Studies of insulin, growth hormone and prolactin bin ding: tissue distribution, species Variation and characterization. Endocrinology 96: 521–531CrossRefGoogle Scholar
  55. Rappaport R, Czernichow P, Prevost C, Jullien M (1977) Retard de croissance avec somathoormone circulante elevee et incapacite ä generer la somatomedine (nanisme de type Laron). Ann Pediatr (Paris) 24: 63–67Google Scholar
  56. Root AW (1972) Human pituitary growth hormone. Thomas, Springfield, III, p 31 Saldanha PH, Toledo SPA (1981) Famüial dwarfism with IR-GH: Report of two affected sibs with genetic and epidemiologic considerations. Hum Genet 59: 367–372Google Scholar
  57. Salmon WD, Daughaday WH (1957) A hormonally controlled serum factor which stimulates sulfate incorporation by cartilage in vitro. J Lab Clin Med 49: 825–836PubMedGoogle Scholar
  58. Schalch DS, Heinrich UE, Draznin B, Johnson CJ, Müler LL (1979) Role of the liver in regulating somatomedin activity; hormonal effects on the synthesis and release of insulin like growth factor and its carrier protein by the isolated perfused rat liver. Endocrinology 104: 1143–1151PubMedCrossRefGoogle Scholar
  59. Scharf A, Laron Z (1972) Skull changes in pituitary dwarfism and the Syndrome of familial dwarfism with high plasma immunoreactive growth hormone. A reontgenologic study. Horm Metab Res 4: 93–97Google Scholar
  60. Schoenle E, Zapf J, Humbel RE, Froesch ER (1982) Insulin-like growth factor I stimulates growth in hypophysectomized rats. Nature 296: 252–253PubMedCrossRefGoogle Scholar
  61. Shurka E, Laron Z (1975) Adjustment and rehabilitation problems of children and adolescents with growth retardation. I. Familial dwarfism with high plasma immunoreactive human growth hormone. Isr J Med Sei 11: 352–357Google Scholar
  62. Sneid DS, Jacobs LS, Weldon VV, Triveldi BL, Daughaday WH (1975) Radioreceptor inactive growth hormone associated with stimulated secretion in normal subjects. J Clin Endocrinol Metab 41: 471–474PubMedCrossRefGoogle Scholar
  63. Van den Brande JL, DuCaju MVL, Visser HKA, Schopman W, Hacheng WHL, Degenhart HJ (1974) Primary somatomedin deficiency. Arch Dis Child 49: 297–304PubMedCrossRefGoogle Scholar
  64. Zaizov R, Laron Z (1966) Body length and weight at birth and one year of age in different communities in Israel. Acta Paediatr Scand 55: 524–528PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1984

Authors and Affiliations

  • Z. Laron
    • 1
  1. 1.Institute of Pediatrics and Adolescent EndocrinologyBeilinson Medical CenterPetah TikvaIsrael

Personalised recommendations